Dr. Ivy Wilkinson-Ryan, MD

Dr. Wilkinson-Ryan practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Wilkinson-Ryan's NPI, 1760647028, was assigned on July 25, 2008. Dr. Wilkinson-Ryan graduated from Geisel School of Medicine at Dartmouth in 2008. Dr. Wilkinson-Ryan holds New Hampshire license 17142.

Dr. Wilkinson-Ryan's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Wilkinson-Ryan's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Wilkinson-Ryan is also affiliated with Alice Peck Day Memorial Hospital. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Wilkinson-Ryan to 3 more hospitals and 1 medical group, each named with a free account. Dr. Wilkinson-Ryan's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wilkinson-Ryan practices, 5 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Wilkinson-Ryan's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Wilkinson-Ryan is licensed in New Hampshire.

CMS data shows 562 Medicare services from Dr. Wilkinson-Ryan across 11 procedure codes in 2024, for 267 Medicare patients. Medicare paid $70,998 for them.

CMS counts 267 Medicare patients who saw Dr. Wilkinson-Ryan in 2024. The largest group is 65 to 74, with 122 patients. 66% of them have high blood pressure, and 63% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wilkinson-Ryan's median patient age at 63, with 99% women.

In 2024, Dr. Wilkinson-Ryan wrote 670 Medicare Part D claims for 137 patients. 84% of them were for generic drugs. CMS names the drug for 513 of them, across 19 drugs with 11 or more claims each, at $425,031 in total drug cost. In 2023, CMS named 353 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Wilkinson-Ryan for performance year 2024, reported as part of a group. Dr. Wilkinson-Ryan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wilkinson-Ryan as offering telehealth. CMS counts 45 procedures of removal of the uterus by Dr. Wilkinson-Ryan, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 17 papers to Dr. Wilkinson-Ryan, published from 2013 to 2025. 2014 was the busiest year, with 3. The most frequent topics are Uterine Cervical Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Adenocarcinoma, Clear Cell. Dr. Wilkinson-Ryan has published most often in Gynecol Oncol. Dr. Wilkinson-Ryan's most frequent co-authors are Premal Harish Thaker, MD, Jayanthi Sivasothy Lea, MD and Bradley J. Monk, MD.

CMS Open Payments shows 3 general payments to Dr. Wilkinson-Ryan from 3 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 83% of the total. Genentech, Inc. paid the most, $68.

Dr. Wilkinson-Ryan graduated from Geisel School of Medicine at Dartmouth in 2008.